Page 4 - Read Online
P. 4

Hepatoma Research
               CONTENTS







               1           First cases of MPV17 related mitochondrial DNA depletion syndrome with compound
                            heterozygous mutations in p.R50Q/p.R50W: a case report
                            Shuichiro Umetsu, Ayano Inui, Sohya Kobayashi, Masaru Shimura, Tomoko Uehara, Hajime
                             Uchida, Rie Irie, Tsuyoshi Sogo, Haruki Komatsu, Takako Yoshioka, Kei Murayama, Kenjiro
                             Kosaki, Mureo Kasahara, Tomoo Fujisawa
                            Hepatoma Res 2020;6:1  http://dx.doi.org/10.20517/2394-5079.2019.030


               2           Interim results from ongoing Phase III placebo-controlled, randomized trial of
                            hepcortespenlisimut-L for advanced hepatocellular carcinoma indication
                            Aldar S. Bourinbaiar, Jigjidsuren Chinburen, Purev Batchuluun, Chogsom Munkhzaya, Dandii
                            Oyungerel, Dorjiin Dandii, Galyna A. Kutsyna, Hulan Tsogkhuu, Marina G. Tarakanovskaya, Alan A.
                            Reid, Vika Borisova, Allen I. Bain, Vichai Jirathitikal
                            Hepatoma Res 2020;6:2  http://dx.doi.org/10.20517/2394-5079.2019.25


               3           Response rates to direct antiviral agents among hepatitis C virus infected patients who develop
                            hepatocellular carcinoma following direct antiviral agents treatment
                            Michela Emma Burlone, Stefano Fangazio, Alessandro Croce, Elisa Ceriani, Rachele Rapetti, Cristina
                            Rigamonti, Carlo Smirne, Stelvio Tonello, Paolo Ravanini, Rosalba Minisini, Mario Pirisi
                            Hepatoma Res 2020;6:3  http://dx.doi.org/10.20517/2394-5079.2019.37


               4           Frailty and Liver resection: where do we stand?
                            Georgios S. Sioutas, Ioannis A. Ziogas, Georgios Tsoulfas
                            Hepatoma Res 2020;6:4  http://dx.doi.org/10.20517/2394-5079.2019.43


               5           The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer
                            Nahum Méndez-Sánchez, Alejandro Valencia-Rodríguez, Alfonso Vera-Barajas, Ludovico Abenavoli,
                            Emidio Scarpellini, Guadalupe Ponciano-Rodríguez, David Q.-H. Wang
                            Hepatoma Res 2020;6:5  http://dx.doi.org/10.20517/2394-5079.2019.29


               6           Coffee protection against the development of hepatocellular carcinoma: review article
                            Kellyane S. D. Carvalho , Helma P. Cotrim
                            Hepatoma Res 2020;6:6  http://dx.doi.org/10.20517/2394-5079.2019.027

               7           Animal models for hepatocellular carcinoma arising from alcoholic and metabolic liver diseases
                            Ken Liu,  Jinbiao Chen, Geoffrey W. McCaughan
                            Hepatoma Res 2020;6:7  http://dx.doi.org/10.20517/2394-5079.2019.39


               8           Association between hereditary hemochromatosis and hepatocellular carcinoma: a comprehensive
                            review
                            Aparna Jayachandran, Ritu Shrestha, Kim R. Bridle, Darrell H. G. Crawford
                            Hepatoma Res 2020;6:8  http://dx.doi.org/10.20517/2394-5079.2019.35
   1   2   3   4   5   6   7   8   9